Safety,Effectiveness Study of RP103 in Patients with Cystinosis

• Research type

  Research Study

• Full title

  A Long-Term Open-Label, Safety and Superior Effectiveness Study of Cysteamine Bitartrate Delayed-release Capsules (RP103) in Patients with Cystinosis

• IRAS ID

  119508

• Contact name

  William Van't Hoff

• Contact email

  William.vanthoff@gosh.nhs.uk

• Sponsor organisation

  Raptor Pharmaceuticals

• Eudract number

  2012-002773-64

• Clinicaltrials.gov Identifier

  NCT01733316

• REC name

  London - Bloomsbury Research Ethics Committee

• REC reference

  13/LO/1444

• Date of REC Opinion

  12 Dec 2013

• REC opinion

  Further Information Favourable Opinion